- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 484.7150 ↓ -0.97%
[as on 9 January, 2026]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 0.08% | -0.97% | -0.75% | -0.36% | -1.8% | -2.7% | 24.71% | 16.86% | 20.9% | 12.43% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 96.05% |
0.07% (Arbitrage: 0.00%) |
0.00% |
0.00% |
3.88% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.18% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 7.26% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 5.62% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.41% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.04% |
| Acutaas Chemicals Ltd. | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 3.81% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 3.76% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.49% |
| Jupiter Life Line Hospitals Ltd. | JLHL (INE682M01012) | Healthcare Services | 3.46% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 3.35% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 3.31% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.27% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.15% |
| Krishna Institute of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 3.09% |
| Polymedicure Ltd. | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 2.94% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 2.92% |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.84% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.70% |
| Aether Industries Ltd. | AETHER (INE0BWX01014) | Chemicals & Petrochemicals | 2.58% |
| Concord Biotech Ltd. | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 2.55% |
| Cohance Lifesciences Ltd. | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 2.21% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 2.09% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 1.95% |
| Vijaya Diagnostic Centre Ltd. | VIJAYA (INE043W01024) | Healthcare Services | 1.45% |
| Pfizer Ltd. | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.28% |
| Medplus Health Services Ltd. | MEDPLUS (INE804L01022) | Retailing | 0.93% |
| Sanofi Consumer Healthcare India Ltd. | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 0.89% |
| Gufic Biosciences Ltd. | GUFICBIO (INE742B01025) | Pharmaceuticals & Biotechnology | 0.80% |
| Rainbow Children's Medicare Ltd. | RAINBOW (INE961O01016) | Healthcare Services | 0.67% |
| Lonza Group | US54338V1017 | Pharmaceuticals & Biotechnology | 4.05% |
Debt
| Name | Rating | Weight % |
|---|
| 182 DAY T-BILL 20.11.25 | Sovereign | 0.07% |
Portfolio data is as on date 31 October, 2025
NAV (Net asset value) history
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH - 30 days NAV history
| Date | NAV |
|---|
| 9 January, 2026 | 484.7150 |
| 8 January, 2026 | 489.4400 |
| 7 January, 2026 | 495.8918 |
| 6 January, 2026 | 493.2210 |
| 5 January, 2026 | 487.7916 |
| 2 January, 2026 | 488.3876 |
| 1 January, 2026 | 484.3323 |
| 31 December, 2025 | 484.8290 |
| 30 December, 2025 | 480.2504 |
| 29 December, 2025 | 482.0735 |
| 26 December, 2025 | 485.0783 |
| 24 December, 2025 | 486.2166 |
| 23 December, 2025 | 488.1873 |
| 22 December, 2025 | 489.1875 |
| 19 December, 2025 | 486.7204 |
| 18 December, 2025 | 482.1210 |
| 17 December, 2025 | 483.3939 |
| 16 December, 2025 | 485.5634 |
| 15 December, 2025 | 487.8497 |
| 12 December, 2025 | 488.7432 |
| 11 December, 2025 | 488.0622 |
| 10 December, 2025 | 485.4383 |
| 9 December, 2025 | 486.4757 |
| 8 December, 2025 | 485.7549 |
| 5 December, 2025 | 493.8394 |
| 4 December, 2025 | 495.3089 |
| 3 December, 2025 | 495.9810 |
| 2 December, 2025 | 497.3461 |
| 1 December, 2025 | 498.9075 |
| 30 November, 2025 | 502.2321 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The latest NAV of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH is 484.7150 as on 9 January, 2026.
What are YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 0.08% as on 9 January, 2026.
What are 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are -2.7% as on 9 January, 2026.
What are 3 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 3 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 24.71% as on 9 January, 2026.
What are 5 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 5 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 16.86% as on 9 January, 2026.
What are 10 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 10 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 16.86% as on 9 January, 2026.